« Previous
Next »
Titles
- Gauging the progress of the National Health Information Technology Initiative: perspectives from the field1
- General principles for evaluating the abuse deterrence of generic solid oral opioid drug products1
- Generic Drug User Fee Amendments of 2012: questions and answers related to self-identification of facilities, review of generic drug submissions, and inspections and compliance1
- Good manufacturing practice considerations for responding to COVID-19 infection in employees in drug and biological products manufacturing1